Bicyclol in the treatment of patients with chronic diffuse liver diseases
Introduction. The increase in serum transaminases (ALT and AST) and the persistence of their high values is associated with morbidity and mortality from liver diseases. Bicyclol has anti-inflammatory and antioxidant effects, which formed the basis for this study.Materials and methods. The study enro...
Main Authors: | M. V. Maevskaya, V. D. Lunkov, N. I. Geyvandova, L. K. Palgova, I. Yu. Pirogova, M. K. Prashnova, N. V. Marchenko, E. N. Zinovieva, T. A. Ilchishina, V. T. Ivashkin, P. V. Koroy |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2020-10-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/5830 |
Similar Items
-
Efficacy and Safety of Bicyclol Treatment for Non-Alcoholic Fatty Liver Disease: Results of a Cohort Study
by: I. Yu. Pirogova, et al.
Published: (2018-09-01) -
Stability of Lyophilized Homemade Control Serum After Reconstitution on SGOT and SGPT Levels Stored in Freezer at Temperature (-2° to -4°C) and -20°C for 8 Weeks
by: Kadek Profit Hartani, et al.
Published: (2023-04-01) -
Non-invasive of liver fibrosis diagnostics: the role of serum markers
by: A. F. Sheptulina, et al.
Published: (2024-03-01) -
Evaluation of clinically relevant serum proteins as biomarkers for monitoring COVID-19 severity, and end-organ damage among hospitalized unvaccinated patients
by: Mahetab R. Elhommosani, et al.
Published: (2024-02-01) -
Medicinal herbs and their metabolites with biological potential to protect and combat liver toxicity and its disorders: A review
by: Shahparan Islam Shawon, et al.
Published: (2024-02-01)